Neuropsychiatr Dis Treat October 2008 PMID 19183781

Attention-deficit-hyperactivity disorder and reward deficiency syndrome.

Kenneth Blum, Amanda Lih-Chuan Chen, Eric R Braverman, David E Comings, Thomas J H Chen, Vanessa Arcuri, Seth H Blum, Bernard W Downs, Roger L Waite, Alison Notaro, Joel Lubar, Lonna Williams, Thomas J Prihoda, Tomas Palomo, Marlene Oscar-Berman

Full text PDF Download social card

Mentions

113

Peak: 2 in Dec 2023

across 5 sources since Apr 2020

Extended reach

1,085,691

potential audience

Total likes

41,686

Video views

1,050,891

Mentions per month

Apr 2020 – Jun 2025

Where it's discussed

News90 articles
Blogs15 articles
X / Twitter3 posts
Facebook3 posts
YouTube2 videos

AI synopsis

What people are saying

The discussions highlight key concepts like the role of the DRD2 gene and dopamine in ADHD, with phrases like 'dopamine dysfunction' indicating agreement with the publication's focus. Questions about why attention is emphasized instead of dopamine reflect curiosity, while the use of specific terms and references to the reward cascade reveal an interest in the underlying biology.

AgreementModerate agreement

Most discussions acknowledge the link between ADHD and dopamine dysfunction, showing a general consensus with some questioning current perspectives.

InterestModerate interest

Posts demonstrate a moderate level of curiosity, especially around genetic and neurochemical mechanisms, but lack deep exploration.

EngagementModerate engagement

There is some engagement, such as referencing the reward cascade and questioning terminology, but it remains relatively superficial.

ImpactModerate impact

The discussions suggest that the article influences understanding of ADHD's neurobiological roots but does not provoke significant action or change.

Abstract in brief

The article explains that certain genes, especially those affecting dopamine in the brain's reward system, can make people more likely to develop ADHD and other reward deficiency syndromes by causing low dopamine levels, which makes individuals seek drugs or behaviors that boost dopamine.
A specific gene variant called the DRD2 A1 allele is linked to fewer dopamine receptors, which increases the risk of impulsive, addictive, and compulsive behaviors, including ADHD, by disrupting normal brain reward processing.
The authors suggest that early genetic testing combined with personalized nutraceutical treatments may help reduce ADHD symptoms and that dopamine and serotonin-releasing medications could be effective for managing other related reward deficiency behaviors like addiction.]

Read the full abstract